The Food and Drug Administration announced on Thursday morning its approval of the progestin-only oral contraceptive Opill for over-the-counter use.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
